AI assistant
Sending…
TransMedics Group, Inc. — Director's Dealing 2019
Jun 15, 2019
31201_dirs_2019-06-14_b093d797-3edc-48ce-a4eb-eb14c7befe2c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2019-06-13
Reporting Person: Hassanein Waleed H (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-06-13 | Common Stock | M | 4000 | $0.28 | Acquired | 109429 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-06-13 | Stock Option (Right to Buy) | $0.28 | M | 4000 | Disposed | 2023-05-29 | Common Stock (4000) | Direct |
Footnotes
F1: The option is fully vested.
More from TransMedics Group, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 21
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Feb 27
Annual Report
2026
Feb 24
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 20